OVARIAN CANCER and US: international

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label international. Show all posts
Showing posts with label international. Show all posts

Sunday, April 01, 2012

March 2012 - open access - International Perspectives on Patient Engagement: Results from the 2011 Commonwealth Fund Survey + link to separate blog posting - related issue...Engaging the Already Engaged - 2/2012



International Perspectives on Patient Engagement: Results from the 2011 Commonwealth Fund Survey - The Commonwealth Fund

Key Findings

  • To assess the level of patients’ engagement with their regular doctors, the researchers analyzed responses to survey items on whether the doctor spends enough time with patients, explains things in a way that is easy to understand, and encourages questions. Patients in Norway and Sweden were the least likely to be engaged by their regular providers, with only about one of three responding positively to all three questions. At the top end of the range, at least two of three patients in Australia, New Zealand, Switzerland, the U.K., and the U.S. reported positive care interactions.
  • In seven of the 11 countries—Australia, Canada, the Netherlands, Norway, Sweden, the U.K., and the U.S.—patients with below-average incomes were significantly less likely to have been engaged by their regular doctor in their care. The U.S. stood out for the widest income-based disparities.
  • Survey participants were asked how often the specialist physicians treating them provide opportunities to ask questions about recommended treatments, tell them about their treatment choices, and involve them as much as they would like in decisions about their care. Four-fifths of patients in Switzerland and the U.K. replied “always” or “often” to all three questions, as did two-thirds or more of Dutch, New Zealand, and U.S. respondents. Respondents in France, Germany, Norway, and Sweden were the least likely to report shared decision-making with specialists.
  • In all countries, patients reporting positive communication and engagement with their regular doctor were far more likely to rate the quality of care they received in the past year as “excellent” or “very good.” The difference was greatest in the U.S.: 78 percent of patients who said they were engaged in their care rated the quality of their care highly, compared with 43 percent of those who said they were not engaged.
  • Engaged patients were also less likely to report a medical, medication, or lab test error in the past two years, and had more positive views of the health system as a whole.  
 
                                              ~~~~~~~~~~~~~~~
 
Feb 21, 2012
Tuesday, February 21, 2012. the Commonwealth Fund (Harvard): Who Are We Reaching Through the Patient Portal: Engaging the Already Engaged? http://tinyurl.com/6tqadrd. Blogger Sandi Pniauskas at Tuesday, February 21, 2012 ...

Monday, January 09, 2012

webinar - Wed Jan 11th - 2011 Commonwealth Fund International Health Policy Survey of Sicker Adults



Date: Wed, Jan 11, 2012
Time: 11:30 AM EST
Duration: 1 hour 30 minutes
Host(s): Christine Haran

 2011 Commonwealth Fund International Health Policy Survey of Sicker Adults


Please register for this meeting.
 

Meeting Description:

This webinar will examine the findings of the latest International Health Policy Survey of Sicker Adults in Eleven Countries, conducted in Australia, Canada, France, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, the United Kingdom, and the U.S. 
 
Published in November, the study compared the experiences of adults with complex care needs on financial barriers to care, access to care, care coordination, preventive care, and support for self-management. 
 
International respondents from England, Switzerland, and the Netherlands will comment on survey findings.

Wednesday, July 13, 2011

abstract: A comparison of international breast cancer guidelines - Do the national guidelines differ in treatment recommendations? USA, Canada, Australia, the UK, and Germany



(USA, Canada, Australia, the UK, and Germany)
 CONCLUDING STATEMENT: Considering that the development of guidelines is a very expensive and resource-intensive task the question arises whether the development of national guidelines in numerous countries is worth the effort since the recommendations differ only marginally.

Tuesday, April 19, 2011

abstract: Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations



"...Therefore, the Breast International Group and North American Breast Cancer Group have joined efforts to develop an International Male Breast Cancer Program and to pool epidemiologic data, clinical information, and tumor specimens. This international collaboration will also facilitate the future planning of clinical trials that can address essential questions in the treatment of male breast cancer."

Wednesday, March 02, 2011

HVO Welcomes Society of Gynecologic Oncologists as Sponsor



HVO Welcomes Society of Gynecologic Oncologists

as Sponsor



[Washington, DC - February 26, 2011] - Health Volunteers Overseas is pleased to announce that the Society of Gynecologic Oncologists has joined as a sponsor. According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide. The WHO reports that in 2005, cancer accounted for 7.6 million of all deaths with more than 70% of these cancer deaths occurring in the developing world. WHO projects 9 million people will be dying from cancer in 2015. These startling statistics show the great need for oncology training in the developing world.

Saturday, January 01, 2011

About INCTR - INCTR – International Network for Cancer Treatment and Research



INCTR is located in Brussels.
It currently has branches in Brazil, Canada, Egypt, France, Nepal and the USA and offices in Cameroon, India, Tanzania and the UK.

Reports:
2010 newsletter:

"In 2010, cancer overtook ischaemic heart disease as the leading cause of death in the world. While different groupings of diseases (e.g., combining all cardiovascular disease or dividing cancer into many different types) would produce a different rank order, the point should not be missed that cancer can no longer be ignored by global health policy-makers as a major cause of disability or death, as well as economic loss......."





Wednesday, December 15, 2010

NCI Cancer Bulletin: How to Strengthen Research Partnerships



NCI Cancer Bulletin: Statistical Strength in Numbers: International Clinical Trials for Rare Cancers



“International trials for rare cancers offer many advantages over separate trials done in different countries or regions,” explained Dr. Jack Welch of the Clinical Investigations Branch in NCI’s Cancer Therapy Evaluation Program (CTEP). “By bringing patients together, international trials can accrue faster, and they offer lower collective administrative costs, shared infrastructure, centralized resources, and use of existing networks.”.....On December 10, NCI and the American Society of Clinical Oncology (ASCO) convened a meeting of international stakeholders to explore ways to collaborate across borders on clinical trials for rare cancers. Nearly 100 representatives from 75 institutions participated in the day-long meeting, which was supported by CTEP, NIH’s Office of Rare Diseases Research (ORDR), NCI’s Office of Advocacy Relations (OAR), and ASCO. In addition to representatives from NIH, the FDA, the HHS Office for Human Research Protections, and NCI’s Clinical Trials Cooperative Group Program, attendees included investigators from Canada, France, Italy, Japan, Korea, the United Kingdom, the European Organisation for Research and Treatment of Cancer, and representatives of patient advocacy organizations and the pharmaceutical industry....cont'd

Friday, June 18, 2010

OCATS - Ovarian Cancer Awareness & Treatment in Saskatchewan - ovarian cancer survivors meet again this year



August 14 & 15, 2010 International Gathering of Ovarian Cancer Women Supporting Each Other (ACOR), Regina, SK, Canada.
This event will include a free BBQ Dinner for patients and their partners on the 14th – to register for this contact Darlene at 306-775-1848 or info@ocats.ca

A luncheon for women only on the 15th out at Homestead Hall - a Prairie Girl Experience!

Golfing on the 15th for the guys at the awesome Deer Valley Golf Resort A Block of Rooms have been set aside at the "Regina Inn, for more info or to register under “OCATS Aug 2010”

For more info call Darlene at 306-775-1848 or info@ocats.ca

Wednesday, April 21, 2010

International Cancer Genome Consortium



Note: those studying ovarian cancer -  

 
 
"Once thought of as a single disease, cancer is now understood to be the result of genetic mutations in cells which disrupt normal functions leading to uncontrollable growth. Because mutations are often specific to a particular type or stage of cancer, systematically mapping the changes that occur in each cancer could provide the foundation for research to identify new therapies, diagnostics and preventive strategies."

Monday, April 12, 2010

The winners of the 2010 Gairdner Awards : The Lancet



Medical researchers from the USA, Canada, UK, and France are recognised in this year's Gairdner Awards for their pioneering work in global health and biomedicine
.
Canada's Gairdner Foundation honoured seven medical researchers on April 6 with some of the world's largest annual international research awards.
Gairdner International Awards valued at CAN$100 000 each went to William Catterall of the University of Washington, WA, USA; Pierre Chambon of the Institut de Génétique et de Biologie Moléculaire et Cellulaire near Strasbourg, France; William Kaelin of the Harvard Cancer Center, MA, USA; Peter Ratcliffe of Oxford University, UK; and Gregg Semenza at the Johns Hopkins Institute for Cell Engineering in Baltimore, MD, USA.
Also recognised were Nicholas White of the Mahidol Oxford Tropical Medicine Research Unit at Mahidol University in Bangkok, Thailand, who won the Canada Gairdner Global Health Award, and Cal Stiller, chair of the Ontario Institute for Cancer Research, who won the Canada Gairdner Wightman Award for leadership in medicine in Canada.
Next to the Nobel Prize in Medicine, the Canada Gairdner Awards are the most prestigious global medical research awards, according to the Gairdner Foundation, which was established by Toronto stockbroker James Arthur Gairdner in 1957. The foundation began recognising pioneers in basic science in 1959. In 2008, the Government of Canada endowed CAN$20 million to support the awards.